Видео ютуба по тегу Speaker: Alison Moskowitz

Monoclonal Antibodies for Treatment in Hematologic Malignancies - Alison Moskowitz, MD
Monoclonal Antibodies for Treatment in Hematologic Malignancies - Alison Moskowitz, MD
Dr Alison Moskowitz on the Importance of Patients Understanding Their Diagnosis, Treatment Options
Dr Alison Moskowitz on the Importance of Patients Understanding Their Diagnosis, Treatment Options
Dr Alison Moskowitz: Standard of Care for Hodgkin Lymphoma Depends on Stage of Disease, Patient Age
Dr Alison Moskowitz: Standard of Care for Hodgkin Lymphoma Depends on Stage of Disease, Patient Age
Relapsed & refractory classic Hodgkin lymphoma
Relapsed & refractory classic Hodgkin lymphoma
Speaker spotlight with AusRock 2022 keynote speaker Dr Alison McQuillan
Speaker spotlight with AusRock 2022 keynote speaker Dr Alison McQuillan
Dr. Moskowitz on the ALCANZA Trial in CTCL
Dr. Moskowitz on the ALCANZA Trial in CTCL
Dr. Moskowitz on PET-Adapted Therapy in Advanced Hodgkin Lymphoma
Dr. Moskowitz on PET-Adapted Therapy in Advanced Hodgkin Lymphoma
Personalized approaches to Hodgkin lymphoma
Personalized approaches to Hodgkin lymphoma
International Patient Conference 2022 - Question and Answer (EDT)
International Patient Conference 2022 - Question and Answer (EDT)
COVID-19 Politics and Policy Speaker Series with Alison Ciborowski
COVID-19 Politics and Policy Speaker Series with Alison Ciborowski
Less aggressive approaches in relapsed/refractory Hodgkin lymphoma
Less aggressive approaches in relapsed/refractory Hodgkin lymphoma
What are the latest treatment advances for Hodgkin lymphoma?
What are the latest treatment advances for Hodgkin lymphoma?
Changes in second-line lymphoma treatment
Changes in second-line lymphoma treatment
Incorporating checkpoint-inhibitors into second-line CLL therapy
Incorporating checkpoint-inhibitors into second-line CLL therapy
Brentuximab for second-line lymphoma treatment
Brentuximab for second-line lymphoma treatment
Webinar: Research Roadmap.
Webinar: Research Roadmap.
Angioimmunoblastic T-cell lymphoma treatment
Angioimmunoblastic T-cell lymphoma treatment
Professor Alison Leary - Optimising caseloads for MS Nurses
Professor Alison Leary - Optimising caseloads for MS Nurses
Quality of Life at Diagnosis May Predict Survival for Patients With Aggressive Lymphoma
Quality of Life at Diagnosis May Predict Survival for Patients With Aggressive Lymphoma